René Bernards

René Bernards

Fondatore presso
Agendia, Inc.

Patrimonio netto: 156 250 $ in data 31/05/2026

74 anni
Commercial Services
Health Technology
Health Services

Profilo

René Bernards was the founder of Agendia, Inc. (founded in 2003, Chief Scientific Officer since 2010) and Agendia NV (founded in 2003, Chief Scientific Officer from 2009 to 2010).
Dr. Bernards is currently a Director at the American Association for Cancer Research (since 2018), a Professor-Molecular Carcinogenesis at the University of Utrecht, a Member of The Royal Netherlands Academy of Arts & Sciences, the Head of the Molecular Carcinogenesis Division at Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis, a Member of the National Academy of Sciences, a Member of the American Academy of Arts & Sciences, and an Operational Partner at Gilde Healthcare Partners, Inc. Formerly, Independent Director at Lixte Biotechnology Holdings, Inc. from 2022 to 2025.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
30/06/2025 25.000 ( 0,2% ) 156 250 $ 31/05/2026

Posizioni attive di René Bernards

SocietàPosizioneInizio
Fondatore 01/01/2003
Corporate Officer/Principal -
Corporate Officer/Principal -
Direttore/Membro del Consiglio 01/01/2018
Corporate Officer/Principal -
Corporate Officer/Principal -
Investitore di Private Equity -

Precedenti posizioni note di René Bernards

SocietàPosizioneFine
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Direttore/Membro del Consiglio 01/09/2025
Corporate Officer/Principal 08/01/2020
░░░░░░░ ░░ ░░░░░░░░░ -
Vedi nel dettaglio l'esperienza di René Bernards

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

84

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Health Technology

Miscellaneous

Health Technology

Finance

  1. Mercati
  2. Insiders
  3. René Bernards
-40%: Proroga eccezionale
g
:
:
ENTRA ORA